Author(s):
Anuj S. More, Amol R. Pawar, Pankaj S. Patil, Vikas V. Patil
Email(s):
anujmore39@gmail.com
DOI:
10.52711/0974-4150.2026.00072 
Address:
Anuj S. More¹*, Amol R. Pawar1,2, Pankaj S. Patil¹, Vikas V. Patil¹
1Department of Quality Assurance, Kisan Vidya Prasarak Sansthas Institute of Pharmaceutical Education, Boradi 425428, India.
2 Research Scholar, Sankalchand Patel University, Visnagar 384315, Gujarat, India.
*Corresponding Author
Published In:
Volume - 19,
Issue - 5,
Year - 2026
ABSTRACT:
Three-dimensional (3D) printing, also known as additive manufacturing, has emerged as a transformative platform in pharmaceutical science, creating unprecedented opportunities for personalized medicine and on-demand drug production. Tracing its origins to early photo-sculpture and topographical modelling techniques, 3D printing has since evolved into a versatile manufacturing approach capable of generating complex, patient-specific dosage forms. This review presents a comprehensive account of the historical evolution of 3D printing and its present-day applications in pharmaceutical drug delivery, with particular attention to inkjet-based, extrusion-based, and laser-based printing technologies. The advantages offered by 3D printing—including dose individualization, complex geometries that enable controlled drug release, decentralized manufacturing, and enhanced patient compliance—are critically examined. In parallel, key quality assurance considerations, such as raw material selection, process control, reproducibility, and product performance, are discussed in relation to the different printing modalities. The regulatory landscape governing 3D-printed pharmaceuticals is further analyzed, with emphasis on existing guidance, approval pathways, and gaps within the frameworks established by agencies such as the FDA, EMA, and NMPA. Despite its considerable promise, the broader adoption of pharmaceutical 3D printing continues to be constrained by challenges related to material availability, process standardization, intellectual property protection, and regulatory ambiguity. Overcoming these barriers through harmonized quality standards and adaptive regulatory policy will be essential to fully integrate 3D printing into routine pharmaceutical manufacturing.
Cite this article:
Anuj S. More, Amol R. Pawar, Pankaj S. Patil, Vikas V. Patil. 3D Printing of Pharmaceuticals: Quality Assurance Considerations and Regulatory Challenges. Asian Journal of Research in Chemistry. 2026; 19(5):499-5. doi: 10.52711/0974-4150.2026.00072
Cite(Electronic):
Anuj S. More, Amol R. Pawar, Pankaj S. Patil, Vikas V. Patil. 3D Printing of Pharmaceuticals: Quality Assurance Considerations and Regulatory Challenges. Asian Journal of Research in Chemistry. 2026; 19(5):499-5. doi: 10.52711/0974-4150.2026.00072 Available on: https://www.ajrconline.org/AbstractView.aspx?PID=2026-19-5-13
7. REFERENCES:
1. Willème, F. (1860). Photosculpture. French Patent No. 43,822 (granted in the US in 1864 as Photographing Sculpture).
2. Blanther, J.E. (1892). Manufacture of Contour Relief Maps. U.S. Patent No. 473,901.
3. Scoutaris, N., Alexander, M.R., Gellert, P.R., Roberts, C.J. Inkjet printing as a novel medicine formulation technique. J Control Rel. 2011; 156(2): 179–185.
4. Lorber, B., Hsiao, W.-K., Hutchings, I.M., Martin, K.R. Adult rat retinal ganglion cells and glia can be printed by piezoelectric inkjet printing. Biofabrication. 2013; 6(1): 15001.
5. Kolakovic, R., Viitala, T., Ihalainen, P., Genina, N., Peltonen, J., Sandler, N. Printing technologies in fabrication of drug delivery systems. Expert Opin Drug Deliv. 2013; 10(12): 1711–1723.
6. Buanz, A.B.M., Saunders, M.H., Basit, A.W., Gaisford, S. Preparation of personalized-dose salbutamol sulphate oral films with thermal ink-jet printing. Pharm Res. 2011; 28(10): 2386–2392.
7. Boehm, R.D., Daniels, J., Stafslien, S., Nasir, A., Lefebvre, J., Narayan, R.J. Polyglycolic acid microneedles modified with inkjet-deposited antifungal coatings. Biointerphases. 2015; 10(1): 11004.
8. Acosta-Vélez, G.F., Wu, B.M. 3D Pharming: Direct Printing of Personalized Pharmaceutical Tablets.
9. Deiner, L.J., Farjami, E. Diffuse reflectance infrared spectroscopic identification of dispersant/particle bonding mechanisms in functional inks. JoVE. 2015; 99: e52744.
10. Champion, J.A., Katare, Y.K., Mitragotri, S. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J Control Release. 2007; 121(1–2): 3–9.
11. Katstra, W.E., Palazzolo, R.D., Rowe, C.W., Giritlioglu, B., Teung, P., Cima, M.J. Oral dosage forms fabricated by Three-Dimensional Printing™. J Control Release. 2000; 66(1): 1–9.
12. “ZipDose Technology | Spritam | Aprecia” 2018. https://www.aprecia.com/technology/zipdose.
13. Yu, D.G., Yang, X.L., Huang, W.D., Liu, J., Wang, Y.G., Xu, H. Tablets with material gradients fabricated by three-dimensional printing. J Pharm Sci. 2007; 96(9): 2446–2456.
14. Yu, D.-G., Branford-White, C., Yang, Y.-C., Zhu, L.-M., Welbeck, E.W., Yang, X.-L. A novel fast-disintegrating tablet fabricated by three-dimensional printing. Drug Dev Ind Pharm. 2009; 35(12): 1530–1536.
15. Azad, M.A., Olawuni, D., Kimbell, G., Badruddoza, A.Z.M., Hossain, M., Sultana, T. Polymers for extrusion-based 3D printing of pharmaceuticals: a holistic material–process perspective. Pharmaceutics. 2020; 12(2): 124.
16. Algahtani, M.S., Mohammed, A.A., Ahmad, J., Saleh, E. Development of a 3D printed coating shell to control the drug release of encapsulated immediate-release tablets. Polymers. 2020; 12(6): 1395.
17. Algahtani, M.S., Mohammed, A.A., Ahmad, J. Extrusion-based 3D printing for pharmaceuticals: contemporary research and applications. Curr Pharm Des. 2018; 24(42): 4991–5008.
18. Chia, H.N., Wu, B.M. Recent advances in 3D printing of biomaterials. J Biol Eng. 2015; 9(1): 1–14.
19. Korte, C., Quodbach, J. Formulation development and process analysis of drug-loaded filaments manufactured via hot-melt extrusion for 3D-printing of medicines. Pharm Dev Technol. 2018; 23(10): 1117–1127.
20. Pietrzak, K., Isreb, A., Alhnan, M.A. A flexible-dose dispenser for immediate and extended-release 3D printed tablets. Eur J Pharm Biopharm. 2015; 96 : 380–387.
21. Alhijjaj, M., Belton, P., Qi, S. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing. Eur J Pharm Biopharm. 2016; 108: 111–125.
22. Hull, C.W., inventor; UVP, Inc., assignee. Apparatus for production of three-dimensional objects by stereolithography. United States Patent US 4,575,330 (1986).
23. Wang, J., Goyanes, A., Gaisford, S., Basit, A.W. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. Int J Pharm. 2016; 503(1–2): 207–212.
24. Olakanmi, E.O., Cochrane, R.F., Dalgarno, K.W. A review on selective laser sintering/melting (SLS/SLM) of aluminium alloy powders: processing, microstructure, and properties. Prog Mater Sci. 2015; 74: 401–477.
25. Fina, F., Goyanes, A., Gaisford, S., Basit, A.W. Selective laser sintering (SLS) 3D printing of medicines. Int J Pharm. 2017; 529(1–2): 285–293.
26. Rengier, F., Mehndiratta, A., von Tengg-Kobligk, H., Zechmann, C.M., Unterhinninghofen, R., Kauczor, H.U., Giesel, F.L. 3D printing based on imaging data: review of medical applications. Int J Comput Assist Radiol Surg. 2010; 5: 335–341.
27. Martelli, N., Serrano, C., Van Den Brink, H., Pineau, J., Prognon, P., Borget, I., El Batti, S. Advantages and disadvantages of 3-dimensional printing in surgery: a systematic review. Surgery. 2016; 159: 1485–1500.
28. Leong, K.F., Cheah, C.M., Chua, C.K. Solid freeform fabrication of three-dimensional scaffolds for engineering replacement tissues and organs. Biomaterials. 2003; 24: 2363–2378.
29. Lam, C.X.F., Mo, X.M., Teoh, S.H., Hutmacher, D.W. Scaffold development using 3D printing with a starch-based polymer. Mater Sci Eng C. 2002; 20: 49–56.
30. Hutmacher, D.W., Sittinger, M., Risbud, M.V. Scaffold-based tissue engineering: rationale for computer-aided design and solid free-form fabrication systems. Trends Biotechnol. 2004; 22: 354–362.
31. Wu, C., Luo, Y., Cuniberti, G., Xiao, Y., Gelinsky, M. Three-dimensional printing of hierarchical and tough mesoporous bioactive glass scaffolds with a controllable pore architecture, excellent mechanical strength and mineralization ability. Acta Biomater. 2011; 7: 2644–2650.
32. Korpela, J., Kokkari, A., Korhonen, H., Malin, M., Närhi, T., Seppälä, J. Biodegradable and bioactive porous scaffold structures prepared using fused deposition modeling. J Biomed Mater Res B Appl Biomater. 2013; 101: 610–619.
33. Alhnan, M.A., Okwuosa, T.C., Sadia, M., Wan, K.W., Ahmed, W., Arafat, B. Emergence of 3D Printed Dosage Forms: Opportunities and Challenges. Pharm Res. 2016; 33: 1817–1832.
34. Norman, J., Madurawe, R.D., Moore, C.M.V., Khan, M.A., Khairuzzamana, A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv Drug Deliv Rev. 2017; 108: 39–50.
35. Prasad, L.K., Smyth, H. 3D Printing technologies for drug delivery: a review. Drug Dev Ind Pharm. 2015; 13: 1–13.
36. Jonathan, G., Karim, A. 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems. Int J Pharm. 2016; 499: 376–394.
37. Sandler, N., Preis, M. Printed drug-delivery systems for improved patient treatment. Trends Pharmacol Sci. 2016; 37: 1070–1080.
38. Preis, M., Öblom, H. 3D-printed drugs for children – are we ready yet? AAPS PharmSciTech. 2017; 18: 303–308.
39. Fogarasi, M., Snodderly, K.L., Di Prima, M.A. A survey of additive manufacturing trends for FDA-cleared medical devices. Nat Rev Bioeng. 2023; 1: 687–689.
40. Zopf, D.A., Hollister, S.J., Nelson, M.E., Ohye, R.G., Green, G.E. Bioresorbable airway splint created with a three-dimensional printer. N Engl J Med. 2013; 368(21): 2043–2045.
41. Morrison, R.J., Hollister, S.J., Niedner, M.F., Mahani, M.G., Park, A.H., Mehta, D.K., et al. Mitigation of tracheobronchomalacia with 3D-printed personalized medical devices in pediatric patients. Sci Transl Med. 2015; 7(285): 285ra64.
42. Dzian, A., Živcák, J., Penciak, R., Hudák, R. Implantation of a 3D-printed titanium sternum in a patient with a sternal tumor. World J Surg Oncol. 2018; 16(1): 7.
43. Cruz, R.L.J., Ross, M.T., Powell, S.K., Woodruff, M.A. Advancements in soft-tissue prosthetics part A: the art of imitating life. Front Bioeng Biotechnol. 2020; 8: 121.